Corrigendum to “Pratensein attenuates Aβ-induced cognitive deficits in rats: Enhancement of synaptic plasticity and cholinergic function” [Fitoterapia 101 (2015) 208–217] (Fitoterapia (2015) 101 (208–217), (S0367326X15000283), (10.1016/j.fitote.2015.01.017))
Other Scholarly Work
Wei, L, Lv, S, Huang, Q et al. (2022). Corrigendum to “Pratensein attenuates Aβ-induced cognitive deficits in rats: Enhancement of synaptic plasticity and cholinergic function” [Fitoterapia 101 (2015) 208–217] (Fitoterapia (2015) 101 (208–217), (S0367326X15000283), (10.1016/j.fitote.2015.01.017))
. 157 10.1016/j.fitote.2022.105123
The authors regret the incorrect publication of Figs. 5, 6 and 7 in the original article. The correct figures are presented below. The authors would like to apologise for any inconvenience caused. [Figure presented] Fig. 5 Effect of pratensein on the expression of Aβ1–42 protein. I: sham control group; II: pratensein control group; III: Aβ1–42-treated model control group; IV: 0.05 mg/kg huperzine A-treated group; V-VI: 10 and 20 mg/kg pratensein-treated groups. [Figure presented] Fig. 6 Effects of pratensein on the expression of Aβ-related genes. RT-PCR assay. APP, BACE1, CatB, NEP and IDE mRNA expression were assayed by real-time PCR in the hippocampus. I: sham control group; II: pratensein control group; III: Aβ1–42-treated model control group; IV: 0.05 mg/kg huperzine A-treated group; V-VI: 10 and 20 mg/kg pratensein-treated groups. [Figure presented] Fig. 7 Effects of pratensein on the expressions of synapse plasticity-related proteins in the hippocampus. The bands are a representative of the blot. I: sham control group; II: pratensein control group; III: Aβ1–42-treated model control group; IV: 0.05 mg/kg huperzine A-treated group; V-VI: 10 and 20 mg/kg pratensein-treated groups.
